Impact of COVID-19 on the management of MDS

preview_player
Показать описание
Rami Komrokji, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses the impact of the COVID-19 pandemic on the treatment and management of patients with myelodysplastic syndrome (MDS). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Рекомендации по теме